NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MyavA.01026.a: 4-aminobutyrate transaminase

Target Characteristics

from organism: Mycobacterium avium 104
most recent status: soluble
center reference id: MyavA.01026.a
is community request: False
associated disease: Johne's disease, paratuberculosis
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyavA.01026.a.A1.GE29043 Full length( MyavA.01026.a ) 1 449 GE29043
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
OrthoMCL: OG5_128761
PATRIC ID: fig|243243.7.peg.3396
RefSeq: YP_882652.1
UniProt: A0A0H2ZRI7

Enzyme & Pathway Information

Pathway Pathway ID EC Number
superpathway of 4-aminobutanoate degradation 4AMINOBUTMETAB-PWY 2.6.1.19
superpathway of L-arginine, putrescine, and 4-aminobutanoate degradation ARGDEG-PWY 2.6.1.19
beta-alanine degradation I BETA-ALA-DEGRADATION-I-PWY 2.6.1.19
GABA shunt GLUDEG-I-PWY 2.6.1.19
superpathway of L-arginine and L-ornithine degradation ORNARGDEG-PWY 2.6.1.19
nicotine degradation I (pyridine pathway) P181-PWY 2.6.1.19
glutamate degradation IX (via 4-aminobutyrate) PWY3O-210 2.6.1.19
L-glutamate degradation IV PWY-4321 2.6.1.19
4-aminobutanoate degradation V PWY-5022 2.6.1.19
4-aminobutanoate degradation I PWY-6535 2.6.1.19
4-aminobutanoate degradation III PWY-6536 2.6.1.19
4-aminobutanoate degradation II PWY-6537 2.6.1.19

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MARLEQTRRL VTEIPGPASL ELSKRRAAAV SHAVNVSVPV FVARAGGGIV EDVDGNRLID LGSGIAVTTI GNSAPRVVDA VRAQVAEFTH TCFMVTPYES YVAVAETLNR ITPGAGEKRS VLFNSGAEAV ENAVKVARAY TRKPAVVAFD HAYHGRTNLA MALTAKSMPY KGGFGPFAPE IYRAPLSYPY RDGLLDKELA TDGEKAAARA INIIDGQIGA DSLAAVIIEP IQGEGGFIVP AEGFLPTLLD WCRRNDVLFI ADEVQTGFAR SGAMFACEHE GPNGLEPDLI CTAKAIADGL PLSAVTGRAQ IMDAPHVGGL GGTFGGNPLA CAAALATIET IESDGLIERA RQLERLITEP LLRLQARDDR IGDVRGRGAM IAIELVKSGT AEPDKDLTQR LSVAAHAAGV IVLTCGMFGN IIRLLPPLTI SDELLAEGID ILGGLLADL

NT Sequence
GTGGCCAGGC TCGAGCAGAC TCGCCGACTG GTCACCGAGA TCCCCGGCCC GGCGTCGCTG GAACTGAGCA AACGCCGCGC GGCCGCGGTG TCGCACGCGG TGAACGTCTC GGTGCCGGTG TTCGTCGCCC GCGCCGGCGG CGGCATCGTC GAGGACGTCG ACGGCAACCG GCTCATCGAC CTCGGCTCCG GCATCGCGGT GACCACCATC GGCAATTCGG CGCCCCGGGT GGTCGACGCG GTGCGCGCCC AGGTGGCCGA GTTCACCCAC ACCTGCTTCA TGGTGACGCC GTACGAGTCC TACGTCGCCG TCGCCGAAAC GCTCAACCGG ATCACCCCCG GGGCCGGTGA AAAGCGCTCG GTGCTGTTCA ACTCCGGCGC CGAGGCCGTC GAGAACGCCG TCAAGGTCGC CCGCGCCTAC ACCCGTAAGC CGGCCGTGGT GGCCTTCGAC CACGCCTACC ACGGCCGCAC CAACCTGGCG ATGGCGCTGA CCGCGAAGTC GATGCCCTAC AAGGGCGGCT TCGGCCCGTT CGCGCCGGAG ATCTACCGGG CGCCGCTGTC CTACCCCTAC CGGGACGGGC TGCTCGACAA GGAACTGGCC ACCGACGGGG AGAAGGCCGC CGCGCGGGCC ATCAACATCA TCGACGGCCA GATCGGCGCC GACAGCCTGG CCGCGGTGAT CATCGAACCG ATCCAGGGCG AGGGCGGGTT CATCGTTCCC GCCGAGGGAT TCCTGCCCAC CCTGCTGGAC TGGTGCCGCC GCAACGACGT GCTGTTCATC GCCGACGAGG TGCAGACCGG GTTCGCGCGG TCCGGCGCCA TGTTCGCCTG CGAGCACGAG GGCCCGAATG GTTTAGAGCC GGACCTGATC TGCACCGCCA AGGCCATCGC CGACGGGCTG CCGCTGTCGG CGGTCACCGG CCGCGCCCAG ATCATGGACG CCCCGCACGT CGGGGGCCTG GGCGGCACCT TCGGCGGCAA CCCGCTGGCG TGCGCGGCGG CGCTGGCCAC CATCGAGACG ATCGAGAGCG ACGGCCTGAT CGAACGGGCC CGGCAGCTGG AACGCCTGAT CACCGAACCG CTGCTGCGCC TGCAGGCCCG CGACGACCGG ATCGGCGACG TCCGCGGCCG GGGCGCCATG ATCGCCATCG AACTGGTGAA GTCCGGCACC GCCGAGCCGG ACAAGGACCT GACCCAGCGG CTGTCCGTCG CCGCGCACGC GGCCGGCGTC ATCGTGCTCA CCTGCGGCAT GTTCGGCAAC ATCATCCGGC TGCTGCCGCC GCTGACCATC AGCGACGAGC TGCTCGCCGA GGGCATCGAC ATTCTCGGCG GGTTGTTGGC CGACCTG

© 2022 Seattle Children's Research Institute. All rights reserved.